BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23955078)

  • 1. The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.
    Leufke C; Leykauf J; Krunic D; Jauch A; Holtgreve-Grez H; Böhm-Steuer B; Bröcker EB; Mauch C; Utikal J; Hartschuh W; Purdie KJ; Boukamp P
    Oncogene; 2014 Jul; 33(27):3506-18. PubMed ID: 23955078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
    Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
    Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
    Perrem K; Lynch A; Conneely M; Wahlberg H; Murphy G; Leader M; Kay E
    Hum Pathol; 2007 Feb; 38(2):351-8. PubMed ID: 17134737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
    Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
    Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.
    Hameetman L; Commandeur S; Bavinck JN; Wisgerhof HC; de Gruijl FR; Willemze R; Mullenders L; Tensen CP; Vrieling H
    BMC Cancer; 2013 Feb; 13():58. PubMed ID: 23379751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas.
    Popp S; Waltering S; Herbst C; Moll I; Boukamp P
    Int J Cancer; 2002 May; 99(3):352-60. PubMed ID: 11992403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma.
    Toll A; Salgado R; Yébenes M; Martín-Ezquerra G; Gilaberte M; Baró T; Solé F; Alameda F; Espinet B; Pujol RM
    Br J Dermatol; 2009 Nov; 161(5):1112-8. PubMed ID: 19673870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in melanoma and non-melanoma skin cancer.
    Parris CN; Jezzard S; Silver A; MacKie R; McGregor JM; Newbold RF
    Br J Cancer; 1999 Jan; 79(1):47-53. PubMed ID: 10408692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin phenotypes can offer some insight about the association between telomere length and cancer susceptibility.
    Ribero S; Mangino M; Bataille V
    Med Hypotheses; 2016 Dec; 97():7-10. PubMed ID: 27876133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
    Griewank KG; Murali R; Schilling B; Schimming T; Möller I; Moll I; Schwamborn M; Sucker A; Zimmer L; Schadendorf D; Hillen U
    PLoS One; 2013; 8(11):e80354. PubMed ID: 24260374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression.
    Bito T; Ueda M; Ahmed NU; Nagano T; Ichihashi M
    J Cutan Pathol; 1995 Oct; 22(5):427-34. PubMed ID: 8594075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J; Rass K
    Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes.
    Queen D; Shen Y; Trager MH; Lopez AT; Samie FH; Lewin JM; Niedt GW; Geskin LJ; Liu L
    FASEB J; 2020 Sep; 34(9):13022-13032. PubMed ID: 32776588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
    Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
    Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas.
    Toll A; Salgado R; Yébenes M; Martín-Ezquerra G; Gilaberte M; Baró T; Solé F; Alameda F; Espinet B; Pujol RM
    Exp Dermatol; 2010 Feb; 19(2):151-3. PubMed ID: 20156290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis.
    Nagano T; Ueda M; Ichihashi M
    Arch Dermatol; 1993 Sep; 129(9):1157-61. PubMed ID: 8363400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.
    Anic GM; Sondak VK; Messina JL; Fenske NA; Zager JS; Cherpelis BS; Lee JH; Fulp WJ; Epling-Burnette PK; Park JY; Rollison DE
    Cancer Epidemiol; 2013 Aug; 37(4):434-9. PubMed ID: 23523330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
    Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
    Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.